HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by TIAA Trust National Association

TIAA Trust National Association decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 94.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,542 shares of the company's stock after selling 24,180 shares during the quarter. TIAA Trust National Association's holdings in HCA Healthcare were worth $463,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the business. First Eagle Investment Management LLC increased its holdings in HCA Healthcare by 0.5% during the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company's stock worth $1,351,830,000 after purchasing an additional 23,177 shares during the period. Franklin Resources Inc. lifted its stake in HCA Healthcare by 11.7% in the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company's stock worth $660,842,000 after acquiring an additional 174,946 shares during the period. Royal London Asset Management Ltd. increased its position in HCA Healthcare by 62.0% during the 4th quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company's stock valued at $450,461,000 after purchasing an additional 574,239 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in HCA Healthcare by 2.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company's stock valued at $604,511,000 after buying an additional 41,190 shares during the period. Finally, Janus Henderson Group PLC lifted its holdings in HCA Healthcare by 12.0% during the third quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company's stock worth $544,467,000 after buying an additional 143,995 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

Remove Ads

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on HCA shares. KeyCorp dropped their price objective on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 7th. Bank of America decreased their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, January 27th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Barclays dropped their price target on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. Finally, Truist Financial dropped their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $385.67.

HCA Healthcare Price Performance

Shares of NYSE:HCA traded up $1.48 during midday trading on Wednesday, reaching $347.21. 237,696 shares of the company's stock traded hands, compared to its average volume of 1,344,017. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The company has a fifty day simple moving average of $325.79 and a two-hundred day simple moving average of $340.25. The company has a market cap of $85.48 billion, a P/E ratio of 15.81, a PEG ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the business posted $5.90 EPS. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were paid a $0.72 dividend. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.83%. The ex-dividend date was Monday, March 17th. HCA Healthcare's dividend payout ratio (DPR) is currently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.